Arabic Arabic English English French French German German
dark

Denali Therapeutics Announces Publication in Cell on New Approach to Treat FTD-GRNPreclinical studies show enhanced brain uptake of progranulin can be achieved using Denali’s Transport Vehicle to cross the blood-brain barrier

Denali Therapeutics Inc. today announced publication of preclinical proof of concept for using its Protein Transport Vehicle (PTV) to enhance brain uptake of peripherally administered progranulin (PTV:PGRN). Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Why Healthcare Orgs Need to Take a Practice-Centered Approach to IT

Next Post

Diadem Announces Publication of Clinical Data Showing Its AlzoSure® Biomarker Test Accurately Predicts Progression to Alzheimer’s Disease Six Years Before Diagnosis

Related Posts
Total
0
Share